Edwards Lifesciences Financials
EWL Stock | EUR 69.55 0.68 0.97% |
Edwards |
Understanding current and past Edwards Lifesciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Edwards Lifesciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Edwards Lifesciences' assets may result in an increase in income on the income statement.
Edwards Lifesciences Stock Summary
Edwards Lifesciences competes with Japan Post, Reinsurance Group, Goosehead Insurance, Plastic Omnium, and China National. Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12800 people.Foreign Associate | USA |
Instrument | Germany Stock View All |
Exchange | Frankfurt Exchange |
ISIN | US28176E1082 |
Business Address | One Edwards Way, |
Sector | Healthcare |
Industry | Medical Devices |
Benchmark | Dow Jones Industrial |
Website | www.edwards.com |
Phone | 949 250 2500 |
Currency | EUR - Euro |
You should never invest in Edwards Lifesciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Edwards Stock, because this is throwing your money away. Analyzing the key information contained in Edwards Lifesciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Edwards Lifesciences Key Financial Ratios
There are many critical financial ratios that Edwards Lifesciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Edwards Lifesciences reports annually and quarterly.Return On Equity | 0.26 | |||
Return On Asset | 0.13 | |||
Target Price | 119.36 | |||
Beta | 1.0 | |||
Z Score | 46.8 |
Edwards Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Edwards Lifesciences's current stock value. Our valuation model uses many indicators to compare Edwards Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Edwards Lifesciences competition to find correlations between indicators driving Edwards Lifesciences's intrinsic value. More Info.Edwards Lifesciences is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Edwards Lifesciences is roughly 1.96 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Edwards Lifesciences' earnings, one of the primary drivers of an investment's value.Edwards Lifesciences Systematic Risk
Edwards Lifesciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Edwards Lifesciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Edwards Lifesciences correlated with the market. If Beta is less than 0 Edwards Lifesciences generally moves in the opposite direction as compared to the market. If Edwards Lifesciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Edwards Lifesciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Edwards Lifesciences is generally in the same direction as the market. If Beta > 1 Edwards Lifesciences moves generally in the same direction as, but more than the movement of the benchmark.
Edwards Lifesciences February 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Edwards Lifesciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Edwards Lifesciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Edwards Lifesciences based on widely used predictive technical indicators. In general, we focus on analyzing Edwards Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Edwards Lifesciences's daily price indicators and compare them against related drivers.
Downside Deviation | 1.54 | |||
Information Ratio | 0.0633 | |||
Maximum Drawdown | 8.88 | |||
Value At Risk | (2.28) | |||
Potential Upside | 3.08 |
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Commodity Directory Find actively traded commodities issued by global exchanges |